Renaissance Technologies LLC 13D and 13G filings for Entero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 2:27 pm Purchase | 2025-09-29 | 13G | Entero Therapeutics, Inc. ENTO | Renaissance Technologies LLC | 86,400 5.440% | 86,400 (New Position) | Filing |